Osteogenic Growth Peptide (10-14) is primarily utilized in biomedical research and therapeutic applications due to its potential to stimulate bone formation and regeneration. It is studied for its role in enhancing osteoblast activity, which is crucial for bone growth and repair. This peptide is explored in the development of treatments for bone-related disorders such as osteoporosis, fractures, and bone defects. Additionally, it is investigated in tissue engineering to promote the integration of bone grafts and implants. Its ability to support bone healing makes it a promising candidate for orthopedic and dental applications, aiming to improve recovery outcomes in patients with bone injuries or degenerative conditions.